2. Zakaria L, Anastasiadis AG, Shabsigh R. Common conditions of the aging male: erectile dysfunction, benign prostatic hyperplasia, cardiovascular disease and depression. Int Urol Nephrol 2001;33:283-292.
4. AUA practice guideline committee. AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: diagnosis and treatment recommendations. J Urol 2003;170:530-547.
5. Roehrborn CG, Malice M, Cook TJ, Girman CJ. Clinical predictors of spontaneous acute retention in man with LUTS and clinical BPH: a comprehensive analysis of pooles placebo broups of several large clinical trials. Urology 2001;58:210-216.
6. Lam JS, Cooper KL, Kaplan SA. Changing aspects in the evaluation and treatment of patient with benign prostatic hyperplasia. Med Clin N Am 2004;88:281-308.
7. Lepor H, Lowe FC. In: Walsh PC, Retic AB, Vauhgan ED, Wein AJ, editor. Evaluation and nonsurgical management of benign prostatic hyperplasia. Campbell's urology 2002;8th ed. Philadelphia: WB Saunders. 1337-1378.
8. Feldman HA, Goldstein I, Hatzichiristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994;151:54-61.
9. Krane RJ, Goldstein I, Saenz De Tajada I. Medical progress: impotence. N Engl J Med 1989;321:1648-1653.
10. Goldstein I, Leu TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral Sildenafil in the treatment of erectile dysfunction. N Engl J Med 1998;338:1397-1404.
11. Sharaby JS, Benet AE, Melman A. Penile revascularization: impotence. Urol Clin North Am 1995;22:699-709.
12. Wespes W, Amar E, Hatzichristou D, Montorsi F, Pryor J, Vardi Y. Guidelines on erectile dysfunction. Eur Urol 2002;41:1-5.
13. Leiblum SR, Rosen RC, Platt M, Cross RC, Black C. Sexual attitudes and behavior of a cross-sectional samples of US medical students: effect gender, age, and year of study. J Sex Educ Ther 1993;19:235.
14. Meuleman EJ, Diemont WL. Investigation of erectile dysfunction: diagnostic testing for vascular factor in erectile dysfunction: impotence. Urol Clin North Am 1995;22:803-819.
15. Broderick GA, Lue TF. In: Walsh PC, Retic AB, Vauhgan ED, Wein AJ, editor. Evaluation and nonsurgical management of erectile dysfunction and priapism. Campbell's urology 2002;8th ed. Philadelphia: WB Saunders. 1619-1671.
16. Kalsi JS, Cellek S, Munneer A, Kell PD, Ralph DJ, Minhas S. Current oral treatemnt for erectile dysfunction. Expert Opin Pharmacother 2002;3:1513-1529.
17. Corbin JD, Francis SH, Webb DJ. Phosphodiesterase type 5 as a pharmacologic target in erectile dysfunction. Urology 2002;60:Suppl 2B. 4-11.